Oppenheimer & Co’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$233K Sell
17,479
-200
-1% -$2.89K ﹤0.01% 1559
2026
Q2
$263K Sell
17,679
-1,956
-10% -$21.1K ﹤0.01% 1534
2026
Q1
$166K Sell
19,635
-1,114
-5% -$12.2K ﹤0.01% 1600
2025
Q4
$234K Sell
20,749
-10,695
-34% -$132K ﹤0.01% 1371
2025
Q3
$472K Buy
+31,444
New +$458K 0.01% 1194

Other funds holding BHVN

Oppenheimer & Co's BHVN Position: Q3 2026 in Review

Oppenheimer & Co reduced its Biohaven (BHVN) stake by 1.1% in Q3 2026, selling an estimated $2.89K and leaving 17,479 shares worth $233K. The position accounts for ﹤0.01% of the portfolio, ranked #1559.

Oppenheimer & Co first reported a position in BHVN in Q3 2025 and has held it in 5 quarters since. The position peaked at $472K in Q3 2025. 304 funds tracked by Wall St. Rank hold BHVN as of Q3 2026.

  • Oppenheimer & Co held 17,479 shares of Biohaven worth $233K as of Q3 2026.
  • Oppenheimer & Co sold 200 Biohaven shares in Q3 2026, an estimated $2.89K.
  • Biohaven made up ﹤0.01% of Oppenheimer & Co's portfolio in Q3 2026, its #1559 holding.
  • Oppenheimer & Co first reported a position in Biohaven in Q3 2025 and has held it in 5 quarters since.
  • Oppenheimer & Co's Biohaven position peaked at $472K in Q3 2025.
  • 304 funds tracked by Wall St. Rank held Biohaven as of Q3 2026.

Based on Oppenheimer & Co's 13F filing for Q3 2026, filed 26 Oct 2026.